Concepedia

David Counsell

DC

Statistics

Publications

12

Citations

2.5K

H-Index

12

Active since

1997

Affiliations

University of Bristol(Current)

University of Oxford

University of Nottingham

Wrexham Maelor Hospital

King's College London

David Counsell is an author at University of Bristol specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.

Publications per year

1997–2024

12

Publications

12

Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists

Tim Cook, David Counsell, J.A.W. Wildsmith · British Journal of Anaesthesia · 2009 · 920 citations · Full text

, , +15

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

, , +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

, , +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

, , +13

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

, , +17

1–5 of 12